These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. Holland MG Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894 [No Abstract] [Full Text] [Related]
23. Chronic effects of miotic drugs. Studies of anticholinesterase activity and functional adaptation to antiglaucoma drugs. KADIN M Arch Environ Health; 1963 Jun; 6():736-41. PubMed ID: 13958207 [No Abstract] [Full Text] [Related]
24. EYE DROPS AND DIARRHEA. DIARRHEA AS THE FIRST SYMPTOM OF ECHOTHIOPHATE IODIDE TOXICITY. MARKMAN HD; ROSENBERG P; DETTBARN WD N Engl J Med; 1964 Jul; 271():197-8. PubMed ID: 14158360 [No Abstract] [Full Text] [Related]
26. OBSERVATION OF DANGEROUS SIDE-EFFECT OF PHOSPHOLINE IODIDE IN GLAUCOMA THERAPY. KLENDSHOJ NC; OLMSTED EP Am J Ophthalmol; 1963 Aug; 56():247-50. PubMed ID: 14061603 [No Abstract] [Full Text] [Related]
27. [Clinical trial of decamethylene-bis-(N-methyl-carbaminoyl-m-trimethylammonium-phenol) (BC 48) in acute, chronic and secondary glaucoma]. GITTLER R Wien Med Wochenschr; 1959 Oct; 109():806-8. PubMed ID: 13828238 [No Abstract] [Full Text] [Related]
28. COMPARISON BETWEEN PILOCARPINE AND ECHOTHIOPHATE FOR CHRONIC SIMPLE GLAUCOMA. A COMPARISON BETWEEN 4 PER CENT PILOCARPINE AND 0.06 PER CENT ECHOTHIOPHATE IODINE IN THE DIURNAL MANAGEMENT OF CHRONIC SIMPLE GLAUCOMA. PRATT-JOHNSON JA; DRANCE SM; INNES R Arch Ophthalmol; 1964 Oct; 72():485-8. PubMed ID: 14191096 [No Abstract] [Full Text] [Related]
30. [Spectacular treatment of thrombosis of the central vein of the retina with an echothiophate collyrium (phospholine iodide)]. PLAMONDON M Laval Med; 1961 Feb; 31():178-82. PubMed ID: 13736196 [No Abstract] [Full Text] [Related]
31. Conservative management of the glaucomas. Phillips CI Trans Ophthalmol Soc U K (1962); 1966; 86():233-45. PubMed ID: 5226576 [No Abstract] [Full Text] [Related]
32. Lcal administration of 1 per cent Ubretid in the handling of glaucoma, myasthenia gravis and esotropia. Ishikawa S; Tsukahara S; Sato Y Ophthalmologica; 1969; 159(4):339-62. PubMed ID: 5393688 [No Abstract] [Full Text] [Related]
33. [1st experiences with echothiophate iodide in the treatment of glaucoma]. MENEZO JL; QUINTANA M Rev Esp Otoneurooftalmol Neurocir; 1962; 21():223-9. PubMed ID: 14472633 [No Abstract] [Full Text] [Related]
34. Antagonism of phospholine (echothiophate) iodide by certain quaternary oximes. LEHMAN RA; NICHOLLS ME Proc Soc Exp Biol Med; 1960; 104():550-4. PubMed ID: 13760444 [No Abstract] [Full Text] [Related]
35. [CLINICAL OBSERVATIONS ON THE USE OF DEMECARIUM BROMIDE IN GLAUCOMA. PHARMACOLOGIC PROPERTIES OF DEMECARIUM AND PHYSOSTIGMINE IN EXPERIMENTS]. GBURKOWA A; POJDA SM Klin Oczna; 1965; 35():207-12. PubMed ID: 14306815 [No Abstract] [Full Text] [Related]
36. Ocular tissue cholinesterases kinetics of enzyme activity and inhibition. Ellis PP Trans Am Ophthalmol Soc; 1971; 69():358-82. PubMed ID: 5005214 [No Abstract] [Full Text] [Related]
38. THE EFFECT OF PHOSPHOLINE IODIDE ON THE DIURNAL VARIATIONS OF INTRAOCULAR PRESSURE IN GLAUCOMA. BARSAM PC; VOGEL HP Am J Ophthalmol; 1964 Feb; 57():241-7. PubMed ID: 14123448 [No Abstract] [Full Text] [Related]